Action L A M Y (PK) - LMMY

L A M Y (PK) (LMMY) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,4381

( - )

Prix Achat

0,4381

Prix Vente

0,4381

Volume échangé

0,00 Fourchette du Jour 0,00

0,0625 Plage de 52 semaines 0,94

Cap du marché

32,2M

Clôture Veille

0,4381

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

US$ 1 720

Actions en circulation

73 500 000

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-56,91

Bénéfice par action (BPA)

-0,01

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

-80,16k

LAMY designs, develops, and operates an eLearning and gaming marketplace platform. It offers TwoPlus1, an educational video game that provides financial knowledge and resource management to children. The company was incorporated in 2022 and is based in New York, New York. LAMY designs, develops, and operates an eLearning and gaming marketplace platform. It offers TwoPlus1, an educational video game that provides financial knowledge and resource management to children. The company was incorporated in 2022 and is based in New York, New York.

Secteur

Industrie

Siège social

New York, United States

Fondé

2026

L A M Y (PK) est coté dans le secteur de la OTC Markets avec le ticker LMMY. Le dernier cours de clôture d'L A M Y (PK) était de US$0,44. Au cours de la dernière année, les actions de L A M Y (PK) ont été négociées dans une fourchette de prix de US$ 0,0625 à US$ 0,94.

L A M Y (PK) compte actuellement 73 500 000 actions en circulation. La capitalisation boursière d'L A M Y (PK) est de US$32,20 million. L A M Y (PK) a un ratio cours/bénéfice (ratio PE) de -56.91.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview

Drawing on over 50 years of drug development experience, Dr. Hausman strengthens the Company’s mission to...

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced...

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY...

Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value

ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0.0781	21.6944444444	0.36	0.4381	0.36	1500	0.37301667	CS
12	0.0881	25.1714285714	0.35	0.47	0.315	1418	0.40608104	CS
26	0.11371	35.0534850026	0.32439	0.5	0.26	1725	0.39995435	CS
52	0.2379	118.831168831	0.2002	0.94	0.0625	3005	0.39779863	CS
156	0.2381	119.05	0.2	16	0.06	9993	3.89253623	CS
260	0.2381	119.05	0.2	16	0.06	9993	3.89253623	CS

LMMY - Frequently Asked Questions (FAQ)

What is the current L A M Y (PK) share price?

The current share price of L A M Y (PK) is US$ 0,4381

How many L A M Y (PK) shares are in issue?

L A M Y (PK) has 73 500 000 shares in issue

What is the market cap of L A M Y (PK)?

The market capitalisation of L A M Y (PK) is USD 32,2M

What is the 1 year trading range for L A M Y (PK) share price?

L A M Y (PK) has traded in the range of US$ 0,0625 to US$ 0,94 during the past year

What is the PE ratio of L A M Y (PK)?

The price to earnings ratio of L A M Y (PK) is -56,91

What is the registered address of L A M Y (PK)?

The registered address for L A M Y (PK) is 201 Allen Street, New York, New York, 10002

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

L A M Y (PK) (LMMY)

L A M Y (PK) (LMMY) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de L A M Y (PK)

LMMY Dernières nouvelles

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

LMMY - Frequently Asked Questions (FAQ)

LMMY Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités